Clinical Trial Update: Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether botulinum toxin injections administered during cardiac surgery can prevent postoperative atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Postoperative Atrial Fibrillation

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Cardiac Surgery | Phase 3 | Status: RECRUITING